WisdomTree International LargeCap Dividend Fund reports 13.1% sales growth, but anticipates cautious consumer spending and operational challenges in fiscal 2027.
38th Annual Roth Conference
38th Annual ROTH Conference
Perma-Fix Environmental Services, Inc. reports 29% treatment revenue growth and anticipates stronger second quarter as Hanford cleanup activities ramp up.
LEAT achieves 41% revenue growth in 2025, driven by international demand and innovative products, positioning for sustained long-term shareholder value.
NRX Pharmaceuticals, Inc. Common Stock reduces losses and anticipates key drug approvals, targeting pro forma profitability by year-end 2026 amid strategic growth.
Lithium Argentina AG achieves record production and EBITDA in 2025, enhancing growth outlook with reduced costs and cash position.
QTRH achieves second consecutive quarter of positive adjusted EBITDA, driven by strategic operational improvements and strong demand for technology solutions, setting the stage for growth.
WeRide Inc. American Depositary Shares reports record high revenue of RMB685 million, driven by 210% growth in robotaxi revenue and strong international expansion plans.
Gamehaus Holdings Inc. Class A Ordinary Shares achieves 151% net income growth and expands operating margin to 3.3%, despite a revenue decline in Q2 2026.
Join Helios Technologies, Inc. Investor Day to explore our strategy for doubling growth and enhancing shareholder value through innovation and operational excellence.
ISC achieves significant financial growth in 2025, driven by robust registry operations and new contracts, while outlining strategic initiatives for 2026.
HPS.A achieves 13.9% sales growth in 2025, with record revenue and a robust backlog as it integrates AEG for enhanced service revenue and market reach.
XPeng Inc. American depositary shares achieve first quarterly profit in Q4 2025, boosted by 38.2% revenue growth and strategic expansion in autonomous driving and humanoid robotics.
KBL reports record revenue of $507 million for 2025, fueled by strategic acquisitions and strong performance across healthcare and hospitality segments.
Milestone Pharmaceuticals Inc. Common Shares achieves FDA approval for Cardamist, positioning for growth with strong cash reserves and early prescription success.
Cellectis S.A. American Depositary Shares achieves 100% response rate in pivotal CAR T trials, signaling strong cash position and strategic momentum for 2026
FedEx Corporation reports strong Q3 results with 8% revenue growth and raises FY26 adjusted EPS outlook to $19.30-$20.10 amidst ongoing strategic initiatives.
Tejon Ranch Co. sees 20% increase in farming revenue while net income declines due to one-time costs; governance reforms aim to enhance shareholder alignment.